KALV | KalVista Pharmaceuticals, Inc.
Category: Company
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 242.98M Prev closed: 14.33 Open: 11.75 High: 15.76 Low: 11.7 52 week low: 9.86 52 week high: 34.92 Dividends: No Dividends Next ER: June 8, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast September 7, 2023 July 6, 2023 - / -0.8686- / -March 9, 2023 -0.75 / -0.98- / -December 8, 2022 -0.9 / -1.06- / -September 8, 2022 -0.94 / -1.04- / -view more
Historical Data Date Price Open High Low Vol Change ER May 26, 2023 9.48 9.76 9.86
9.03
247K -2.87% May 25, 2023 9.76 10.39 10.57
9.74
155K -5.97% May 24, 2023 10.38 10.5 10.67
10.33
221K -1.8% May 23, 2023 10.57 10.57 10.95
10.55
166K 0% May 22, 2023 10.57 10.41 10.61
10.1
324K 0.38% May 19, 2023 10.53 10.47 10.76
10.46
159K 1.25% May 18, 2023 10.4 10.27 10.43
9.99
487K 1.07% May 17, 2023 10.29 10.13 10.4
9.93
229K 2.39% May 16, 2023 10.05 10.08 10.16
9.89
230K -0.59% May 15, 2023 10.11 9.7 10.35
9.33
156K 3.27% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
KalVista Pharmaceuticals GAAP EPS of -$0.90 beats by $0.16 seekingalpha.com Dec 8, 2022 7:37 pm KalVista's hereditary angioedema drug's orally disintegrating version shows promise in trial seekingalpha.com Oct 31, 2022 7:56 pm KalVista Pharmaceuticals appoints Brian J.G. Pereira as Board Chairman seekingalpha.com Oct 17, 2022 7:10 pm
KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock finance.yahoo.com Oct 13, 2022 4:01 pm
Why Is KalVista Pharmaceuticals (KALV) Stock Down 50% Today? finance.yahoo.com Oct 13, 2022 11:41 am
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement finance.yahoo.com Oct 13, 2022 8:09 am KalVista shares slide 47% premarket after company halts trial of treatment for hereditary angioedema marketwatch.com Oct 13, 2022 7:34 am KalVista Reports Positive Test Results for Angioedema Drug; Shares Soar thestreet.com Oct 13, 2022 4:35 am
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Oct 13, 2022 7:00 am
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Oct 13, 2022 7:00 am
KalVista Pharmaceuticals Presents New Data for Sebetralstat and its Oral Factor XIIa Inhibitor Program finance.yahoo.com Oct 13, 2022 6:45 am
KalVista Pharmaceuticals Provides Regulatory Update for Phase 2 Clinical Trial of KVD824 finance.yahoo.com Oct 13, 2022 6:30 am
KalVista Pharmaceuticals Announces the Lifting of FDA Clinical Hold for Phase 2 Trial of KVD824 finance.yahoo.com Oct 13, 2022 6:30 am
Introducing KalVista Pharmaceuticals (NASDAQ:KALV), The Stock That Zoomed 244% In The Last Three Years finance.yahoo.com Oct 13, 2022 5:53 am DWAC, DCT and PENN are among after hour movers seekingalpha.com Oct 13, 2022 5:03 am
Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound finance.yahoo.com Oct 10, 2022 7:58 pm
KalVista (KALV) Stock Continues to Decline: Here's Why finance.yahoo.com Oct 6, 2022 1:50 pm
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Oct 5, 2022 7:00 am KalVista stock slumps 37% as KVD824 trial for hereditary angioedema ended over liver safety concerns seekingalpha.com Oct 4, 2022 7:24 pm
KalVista Pharmaceuticals to Present at the 2022 HAEi Global Leadership Workshop finance.yahoo.com Sep 30, 2022 6:45 am This company doesn't provide a dividend.
Key Persons Talk about KalVista Pharmaceuticals, Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
